Preview — Barron's
Johnson & Johnson JNJCO
News
Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief — Update
J&J Says In-Development Blood-Cancer Treatment Shows Promise
Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint
Johnson & Johnson Gets FDA Approval for Imaavy to Treat Warm Autoimmune Hemolytic Anemia
Moderna's cancer-vaccine breakthrough drives broad biopharma stock rally
Johnson & Johnson on Track for Record High Close — Data Talk
Johnson & Johnson On Pace for Record High Close — Data Talk
Johnson & Johnson Pharmaceuticals Leader Jennifer Taubert to Retire
Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines
Johnson & Johnson Agrees to Pay Up to $5.5 Billion to Settle Talc Lawsuits — Update
Johnson & Johnson Agrees to Pay Up to $5.5 Billion to Settle Talc Lawsuits
Johnson & Johnson Skin Drug Gets Positive Opinion From EU Drug Regulator
J&J Says In-Development Blood Cancer Treatment Can Reduce Risk of Death, Disease Progression
Johnson & Johnson Gets FDA OK for Ottava Robotic Surgical System
J&J's DePuy Synthes Acquires Expanding Innovations
Healthcare stocks have become a haven for investors ditching tech
Johnson & Johnson on Track for Record High Close — Data Talk
Johnson & Johnson on Pace for Largest Percent Decrease Since May 2025 — Data Talk
Johnson & Johnson Investing $1 Billion in Florida to Expand Vision Operations
United States